Warning: The NCBI web site requires JavaScript to function. more...
Regulation of cancer stem cells by p53.
Jerry DJ, Tao L, Yan H.
Breast Cancer Res. 2008;10(4):304. Epub 2008 Aug 29.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.
Galmarini CM, Clarke ML, Falette N, Puisieux A, Mackey JR, Dumontet C.
Int J Cancer. 2002 Feb 1;97(4):439-45.
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.
Shafee N, Smith CR, Wei S, Kim Y, Mills GB, Hortobagyi GN, Stanbridge EJ, Lee EY.
Cancer Res. 2008 May 1;68(9):3243-50.
The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.
Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP, Pelicci PG.
Cell. 2009 Sep 18;138(6):1083-95.
Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
Jerry DJ, Ozbun MA, Kittrell FS, Lane DP, Medina D, Butel JS.
Cancer Res. 1993 Jul 15;53(14):3374-81.
The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE.
Cancer Res. 2008 Oct 1;68(19):7711-7.
p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
Megha T, Ferrari F, Benvenuto A, Bellan C, Lalinga AV, Lazzi S, Bartolommei S, Cevenini G, Leoncini L, Tosi P.
J Clin Pathol. 2002 Jun;55(6):461-6.
Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
Ku TK, Nguyen DC, Karaman M, Gill P, Hacia JG, Crowe DL.
Mol Cancer Res. 2007 Apr;5(4):351-62.
p53 suppresses the self-renewal of adult neural stem cells.
Meletis K, Wirta V, Hede SM, Nistér M, Lundeberg J, Frisén J.
Development. 2006 Jan;133(2):363-9.
Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Rydén L, Luts L, Bendahl PO, Hedenfalk I.
Breast Cancer Res Treat. 2010 Jul;122(2):315-24. Epub 2009 Oct 1.
Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.
Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE, Michalowska AM, Rosen JM.
Cancer Res. 2008 Jun 15;68(12):4674-82.
Loss of p53 protein during radiation transformation of primary human mammary epithelial cells.
Wazer DE, Chu Q, Liu XL, Gao Q, Safaii H, Band V.
Mol Cell Biol. 1994 Apr;14(4):2468-78.
Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.
Ko SC, Gotoh A, Thalmann GN, Zhau HE, Johnston DA, Zhang WW, Kao C, Chung LW.
Hum Gene Ther. 1996 Sep 10;7(14):1683-91.
Regulation of p53 protein expression in human breast cancer cell lines.
Vojtĕsek B, Lane DP.
J Cell Sci. 1993 Jul;105 ( Pt 3):607-12.
The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells.
Huang C, Zhang XM, Tavaluc RT, Hart LS, Dicker DT, Wang W, El-Deiry WS.
Cancer Biol Ther. 2009 Nov;8(22):2186-93. Epub 2009 Nov 27.
Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
Pommier SJ, Quan GG, Christante D, Muller P, Newell AE, Olson SB, Diggs B, Muldoon L, Neuwelt E, Pommier RF.
Ann Surg Oncol. 2010 Feb;17(2):613-23. Epub 2009 Oct 17.
Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
Eastham JA, Grafton W, Martin CM, Williams BJ.
J Urol. 2000 Sep;164(3 Pt 1):814-9.
Apoptosis inhibitor as a suppressor of tumor progression: expression of Bcl-2 eliminates selective advantages for p53-deficient cells in the tumor.
Gurova KV, Kwek SS, Koman IE, Komarov AP, Kandel E, Nikiforov MA, Gudkov AV.
Cancer Biol Ther. 2002 Jan-Feb;1(1):39-44.
Integrative genomics revealed RAI3 is a cell growth-promoting gene and a novel P53 transcriptional target.
Wu Q, Ding W, Mirza A, Van Arsdale T, Wei I, Bishop WR, Basso A, McClanahan T, Luo L, Kirschmeier P, Gustafson E, Hernandez M, Liu S.
J Biol Chem. 2005 Apr 1;280(13):12935-43. Epub 2005 Jan 18.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on